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Abstract
Objective
To assess the usefulness of corneal esthesiometry for screening diabetic retinopathy.
Methods
A cross-sectional study was carried out comprising 575 patients attending a diabetic
retinopathy-screening program in the city of São Paulo. Corneal esthesiometry was
assessed with the Cochet-Bonnet esthesiometer. The presence of diabetic retinopathy
was detected with indirect fundoscopy. The validity of corneal esthesiometry in
identifying diabetic retinopathy was evaluated by the Receiver Operating Characteristic
(ROC) curve.
Results
Sensitivity and specificity analyses of the corneal esthesiometry for detecting the
stages of diabetic retinopathy using different cut-offs showed values less than 80%.
The best indices (72.2% sensitivity and 57.4% specificity) were obtained for the
identification of patients with proliferative diabetic retinopathy.
Conclusions
In the study series, corneal esthesiometry was not a good indicator of diabetic retinopathy.
Resumo
Objetivo
Avaliar a utilidade da estesiometria corneal na triagem da retinopatia diabética.
Métodos
Foi realizado um estudo transversal (N=575) em um programa de triagem de
retinopatia diabética da Cidade de São Paulo, SP. A sensibilidade corneal foi
aferida utilizando-se o estesiômetro de Cochet-Bonnet. A avaliação da retinopatia
diabética foi obtida por meio da fundoscopia indireta. A validade do uso da
estesiometria corneal na identificação de pacientes com retinopatia diabética foi
avaliada por meio de curvas de sensibilidade e especificidade (Receiver Operating
Characteristics (ROC) curve).
Resultados
A análise da sensibilidade e da especificidade da estesiometria corneal na detecção
dos diferentes graus de retinopatia, utilizando-se diferentes pontos de corte, mostrou
resultados inferiores a 80%. O melhor resultado obtido ocorreu na identificação de
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pacientes com retinopatia diabética proliferativa, mostrando sensibilidade de 72,2%
e especificidade de 57,4%.
Conclusões
Na série analisada, a estesiometria corneal não se mostrou um bom indicador da
presença da retinopatia diabética.
INTRODUCTION
Diabetes, particularly diabetic retinopathy (DR), is
the leading cause of new cases of blindness in adults
in the United States and it is an increasing problem in
Brazil due to the population aging. There is need to
screen an enormous population of diabetic patients
to identify those on risk of blindness and then be
able to provide them treatment.7,10
The screening method considered to be the gold-
standard in identifying DR and its different stages is
the fundus photography.1 This method not only re-
quires expensive equipment but also implies recur-
rent cost. The current screening method in Brazil is
the indirect ophthalmoscopy.10
The first description of corneal hypoesthesia in a
diabetic patient credited the decreased sensitivity to
the concomitant glaucoma.3 In 1974 it was demon-
strated that diabetic patients had a significant lower
esthesiometry when compared to controls17 but this
study did not compare the relation to DR. In 1975
another study using the same data reported the use-
fulness of corneal esthesiometry to differentiate dia-
betic from non-diabetic patients.5 The first citation
of corneal esthesiometry being able to differentiate
the stages of DR was published in 1980.12 The use of
corneal esthesiometry for screening DR with promis-
ing results was published in 1996.15 The principle of
this screening method is that corneal hypoesthesia
and diabetic retinopathy are caused by a common
factor (systemic disease) and tend to start and progress
somewhat simultaneously.
The possibility of screening DR using a simpler
method or even a device that could be handled by
non-ophthalmologists has been explored. Methods
assessing other features of diabetic cornea (autofluo-
rescence18 and epithelial fragility14) have been pro-
posed. Using esthesiometry would be less cumber-
some and it is also the most inexpensive of these
methods. The Cochet-Bonnet esthesiometer is a port-
able non-electric device and its ability to identify
DR was found to be similar to autofluorescence and
epithelial fragility.15
Although the treatment of DR eventually demands
an ophthalmoscopy, screening diabetic population
with Cochet-Bonnet could maximize the capability
of the public health system by helping non-oph-
thalmologists to identify those patients that should
be referred to the ophthalmologist. Nevertheless,
using esthesiometry for that purpose should only
be advisable if the high sensitivity and specificity
previously reported15 were reproduced in a large dia-
betic population when compared to the current
screening method.
It was compared corneal esthesiometry of diabetic
patients of a diabetic retinopathy screening program
with of DR (and its stage) detection data using indirect
ophthalmoscopy to assess the usefulness of corneal
esthesiometry for screening diabetic retinopathy.
METHODS
This study was designed to test corneal esthesiom-
etry as a diagnostic tool for diabetic retinopathy. In-
direct ophthalmoscopy was the gold-standard exam.
A cross-sectional study was carried out in a DR
screening program in the city of São Paulo. The study
population was formed by individuals who sponta-
neously engaged in the aforementioned program.
The studied screening program provides treatment
to all populations with no restriction of residence
area and even accepts patients from other cities.
Screenings are usually held on a monthly basis. The
selection was made after an interview and a biomi-
croscopy evaluation. There was no refusals to partici-
pate in the study. None of the subjects refused to be
interviewed or to undergo biomicroscopy and indi-
rect ophthalmoscopy. Patients with previous bilat-
eral ocular surgery (N=18), chronic use of topical
medication (N=16), external eye disease (N=10), early
(<35y) diagnosis of diabetes (N=30) or corneal, lens
or vitreous opacity not allowing indirect fundoscopy
(N=8) were excluded. Age (F=0.42, p=0.52), gender
(X=0.26, p=0.60) and proportion of different stages
of DR (X=3.36, p=0.49) did not differ between in-
cluded (N=575) and excluded patients (N=82).
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Included patients underwent corneal esthesiometry
before indirect fundoscopy. Corneal esthesiometry
was obtained using the Cochet-Bonnet esthesiometer
under good illumination. Initially the nylon filament
was fully extended to 60 mm. The tip of the fiber was
steadily advanced towards the cornea. When the ex-
aminer detected that the end plate of the nylon fila-
ment was in contact with the cornea a mild pressure
was exerted such that the fiber had the slightest bend
just visible. The response was considered to be posi-
tive either by the patient’s subjective response or
objective blinking. If a positive answer was not de-
tected the fiber length was shortened in steps of 5
mm each time and the procedure was repeated until
there was a positive response. The readings were taken
in the central cornea. The procedure was repeated
three times. The values in millimeters were converted
into pressure units (g/mm2) according to the data pro-
vided by the manufacturer. All measurements were
performed by the same examiner.
To allow the analysis of eyes that did not present a
positive response with the shortest length (5 mm) of
the esthesiometer fiber the reciprocal of the pressure
unit was used. Eyes with no response were classified
as having no sensitivity and their pressures were con-
sidered to be a maximum value (infinite). All data in
g/mm2 were transformed into mm2/g and those eyes
were labeled with the minimum value (zero).
Corneal esthesiometry of each patient was classi-
f ied as both arithmetical mean (two eyes) and
esthesiometry of the less sensitive eye.
After esthesiometry, patients underwent detailed
indirect ophthalmoscopy. Each patient was assigned
to one of the following groups according to the most
severe stage of retinopathy detected. The following
classification was based on the Early Treatment Dia-
betic Retinopathy Study definitions:6 normal (NoDR)
– no alteration considered to be due to DR; mild non-
proliferative diabetic retinopathy (MNPDR) – micro-
aneurisms, intraretinal hemorrhages in less than four
quadrants and hard exudates; moderate non-prolif-
erative diabetic retinopathy (MoNPDR) – cotton-wool
spots, intraretinal hemorrhages in four quadrants,
venous beading and intraretinal microvascular ab-
normalities (IRMA); severe non-proliferative diabetic
retinopathy (SNPDR) – presence of intraretinal hem-
orrhages in four quadrants, venous beading in two
quadrants or IRMA in one quadrant; proliferative
diabetic retinopathy (PDR) – neovascularization of
the disc and/or retina. The presence of typical retinal
scar was considered to be an indicator of previous
retinal photocoagulation.
Data was processed using the NCSS Statistical Soft-
ware (NCSS, PASS), 2000 Edition. All tests were ana-
lyzed at a level of 0.05 significance. Anderson-Dar-
ling normality test was used to assess the normality
of age and esthesiometry distribution. Numeric vari-
ables showed normal distribution in all the studied
groups. The esthesiometry did not show an equal vari-
ance among the groups and data was log-transformed.
One-way ANOVA and post-hoc Bonferroni test were
used in numeric data comparisons. The correlation
between the two values (mean/less sensitive eye) of
corneal esthesiometry was analyzed using the Pearson
correlation coefficient. Proportion of nominal vari-
ables was compared applying the Chi-square test.
Yates correction for continuity was applied in com-
parisons with only one degree of freedom.
The quality of corneal esthesiometry for screening
DR was tested by the construction of Receiver Oper-
ating Characteristic (ROC) curves. For that the stud-
ied population was divided in three different ways:
patients without DR/patients with any degree of DR;
patients without DR or mild non-proliferative DR/
patients with any other stage of DR; patients without
proliferative DR/patients with proliferative DR. For
each division a curve was constructed to identify the
power (sensitivity/specificity) of the esthesiometry
in indicating the difference between the groups. The
curves were analyzed by the area underneath it8 and
sensitivity/specificity at the best cut-off.
This study was approved by the Ethical Committee
of the “Universidade Federal de São Paulo”.
RESULTS
The mean age of included patients was 60.4 years
(SD 9.6) and there was a slight predominance of fe-
Table 1 – Demographic features of  included patients according to the presence and stage of diabetic retinopathy.
Feature NoDR MNPDR MoNPDR SNPDR PDR
(N=282) (N=90) (N=71) (N=24) (N=108)
Age (yrs)
(Mean ± SD) 60.6±9.7 61.6±9.1 63.6±10.7 63.7±8.9 59.9±9.3
F=0.36; p=0.78
Gender (%) Male 48.9 43.3 51.4 29.2 48.2
X2=4.72; p=0.32 Female 51.1 56.7 48.6 70.8 51.8
NoDR – Absence of diabetic retinopathy, MNPDR, MoNPDR, SNPDR – Mild, moderate, and severe non-proliferative
diabetic retinopathy, respectively; PDR – Proliferative diabetic retinopathy.
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male patients (52.5%). These variables did not differ
among the groups when patients were divided ac-
cording to the stage of DR (Table 1).
It was detected a high correlation (r=0.933; p<0.001)
between the two values (mean/less sensitive) of cor-
neal esthesiometry. The distribution of the less sensi-
tive eye esthesiometry according to the stage of DR
is shown on Figure 1.
The comparison of these values showed that esthe-
siometry differed among the groups (F=24.32,
p<0.001). Bonferroni post-testing indicated that cor-
neal esthesiometry of patients with NoDR was less
decreased than all the other groups (p<0.05). Among
patients with any degree of DR the esthesiometry was
similar only in groups adjacent in the DR severity
spectrum (p>0.05 in the following comparisons:
MNPDR x MoNPDR, MoNPDR x SNPDR, and
SNPDR x PDR). All the others showed a significant
difference (p<0.05) in esthesiometry when the groups
were compared.
The distribution of corneal esthesiometry accord-
ing to the presence of previous retinal photocoagula-
tion in all different stages of DR is shown in Table 2.
Forty-nine eyes were not included in the analysis due
to previous ocular surgery (N=37) or chronic use of
topical medication (N=12). The difference detected
when eyes with previous photocoagulation were com-
pared to those without a scar was not present in com-
parisons within each group of DR.
The ROC curves provided by the mean esthesiom-
etry (between eyes) and the one corresponding to
the less sensitive eye were similar in all the three
sample subgroups. The area underneath the curves
showed values from 0.655 to 0.736. The best area
and the best sensitivity and specificity values were
detected in patients with proliferative DR (Figure
2). Using a cut-off of 0.58 mm2/g patients with pro-
liferative DR were detected with 72.2% sensitivity
and 57.4% specificity.
DISCUSSION
Blindness related to DR can only be prevented by
providing diabetic patients an early diagnosis and
treatment.7 Not all diabetic patients have access to
ophthalmology centers and a simple but effective
screening would be beneficial, especially in devel-
oping countries. An ideal method of screening dia-
betic patients should be not expensive, be widely
available, and feasible in the public health system.
Corneal esthesiometry suits that but despite previ-
ous encouraging results,15 its validity in screening
diabetic patients has not been proved.
As the studied population spontaneously sought
medical assistance, there may be a population bias
with a higher number of severe cases (decrease in
visual acuity) than the actual incidence of severe cases
in the population. For that reason the predictive val-
Table 2 – Corneal esthesiometry according to the presence of retinal photocoagulation scar and the stage of diabetic
retinopathy (per eye analysis). (N=1,101)
Diabetic Retinopathy Photocoagulation scar
Absent Present
% Esthesiometry (mm2/g) % Esthesiometry (mm2/g) p*
(Mean ± S.D.) (Mean ± S.D.)
NoDR (N=555) 100.0 0.86±0.13 0 -
MNPDR (N=180) 92.8 0.85±0.12 7.2 0.82±0.07 0.56
MoNPDR (N=138) 81.9 0.46±0.16 18.1 0.46±0.20 0.87
SNPDR (N=50) 80.0 0.26±0.13 20.0 0.26±0.12 0.95
PDR (N=178) 81.5 0.27±0.11 18.5 0.26±0.15 0.81
Total (N=1,101) 92.6 0.71±0.27 7.4 0.41±0.25 <0.001
NoDR – Absence of diabetic retinopathy, MNPDR, MoNPDR, SNPDR – Mild, moderate, and severe non-proliferative
diabetic retinopathy, respectively; PDR – Proliferative diabetic retinopathy.
*One-way ANOVA.
Figure 1 - Distribution of corneal esthesiometry of the less
sensitive eye according to the stage of diabetic retinopathy.
NoDR – Absence of diabetic retinopathy, MNPDR, MoNPDR, SNPDR – Mild, moderate,
and severe non-proliferative diabetic retinopathy, respectively; PDR – Proliferative
diabetic retinopathy.
Median is the square in the center of the box. The top and bottom of the box are 25 and
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ues (positive and negative) of corneal esthesiometry
found in this series would not be useful when dealing
with screening program with different ways of ac-
cess, particularly in programs based on active search
of patients in the community.
The methods of measuring corneal esthesiometry
and staging DR were chosen based on the availabil-
ity in the Brazilian public health system.10 For cor-
neal esthesiometry the Cochet-Bonnet esthesiometer
is considered the standard method9 and aside from
being the most used instrument for that purpose is
also an easy to handle device.
The use of fundus photographs analyzed in refer-
ence centers could have provided more accurate data
regarding staging DR. Using that information instead
of indirect ophthalmoscopy would not have eluci-
dated whether corneal esthesiometry could provide
similar results when compared with the current meth-
ods available in the Brazilian public health system.
The distribution of esthesiometry in groups with
different stages of DR showed that hypoesthesia is
progressive and parallels DR. This finding is impor-
tant because this is an assumption when trying to use
corneal esthesiometry for screening DR. Neverthe-
less, the analysis of Figure 1 also reveals that despite
the progressive decrease in the median and 25-75
percentiles there is an important overlapping among
the distributions. The distributions stretch through
all the esthesiometry spectrum. This feature indicates
that esthesiometry has limitations in identifying dif-
ferent groups and therefore for screening.
The influence of photocoagulation on the esthesi-
ometry detected when all eyes with presumed photo-
coagulation were compared to eyes without scars (Ta-
ble 2) was not present when the sample was divided
according to DR stage. The total analysis was prob-
ably influenced by the significant predominance of
patients with NoDR in the group without scar.
Alterations on corneal esthesiometry caused by reti-
nal photocoagulation have been cited in the litera-
ture11,12 but this factor was not related to a decrease in
corneal esthesiometry in the present series. Recent
studies with modern lasers have also failed to detect
this relation.13,16 In the study group it might be due to
the fact that scars were not quantitatively analyzed.
Patients with non-proliferative DR probably had fo-
cal laser for macula edema that requires fewer pulses/
low energy and the amount of energy is related to the
induced hypoesthesia.
ROC curves are useful to compare a diagnostic tool
to a gold-standard diagnosis. These curves can only
be used for graded variables. Initially, the studied
population is divided according to the gold-stand-
ard (positive/negative) and the potential diagnostic
variable is measured in each patient. To plot the curve,
the sensitivity and specificity of different cut-offs
(all possible grades of the variable) are determined. If
the distribution of the variable in the positive and
negative groups (determined by the gold standard)
does not overlap the variable is a perfect diagnostic
tool and will show at least one cut-off with 100%
sensitivity and 100% specificity. In such case, the
specificity will only decrease in cut-offs with 100%
sensitivity. Therefore, the area underneath the curve
will be 1.0. When the distribution shows overlapping
between groups, increasing the sensitivity will de-
crease the specificity.
ROC curves are useful to show how the potential
diagnostic variable is capable of reaching high sen-
sitivity without significant decrease in the specificity.
Cut-offs with high sensitivity and specificity values
will cause a left shift in the curve increasing the area
below it. The total absence of diagnostic value for
one variable will be detected if an increase in the
sensitivity is paralleled by an equal decrease in sen-
sitivity. In that case the area underneath the curve
will be 0.5. If the calculated area underneath a ROC
curve is smaller than 0.5 it only indicates that the
relation of the potential diagnostic variable to the
gold-standard (e.g. higher values indicates positive
patient) should be considered the opposite way. There
is no standardization to analyze the areas of ROC
curves. Usually, a suitable diagnostic variable should
present an area larger than the midpoint (0.75) of the
possible range (0.5 to 1.0).
The area under the ROC curves showed small val-
Figure 2 - Receiver Operating Characteristic (ROC) curve
for corneal esthesiometry. Identification of patients with
proliferative diabetic retinopathy.
A – Mean (area =0.736)
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